Professor Jean-Marie Lehn of University of Strasbourg, Nobel Prize Winner and Father of 'Supramolecular Chemistry', appointed Honorary Principal of Huashang College by Edvantage Group
Enable Huashang College Become the Leading Healthcare and Medical Institute with World Class Academic Excellent
HONG KONG, Nov 04, 2019 - (ACN Newswire) - Edvantage Group Holdings Limited ("Edvantage Group" or the "Group", stock code: 0382.HK), is pleased to announce the Group has appointed Professor Jean-Marie Lehn of Chemistry Faculty, University of Strasbourg, the Nobel Prize Winner in Chemistry (1987) and the Father of "Supramolecular Chemistry" as the Honorary Principal of Huashang College, Guangdong University of Finance and Economics ("Huashang College") operated by the Group.
| Mr. Liu Yung Chau, Chairman of the Board of Edvantage Group and Professor Albert Sun-Chi Chan, the Principal of Huashang College presented the Certificate of Appointment to Professor Jean-Marie Lehn |
| Professor Jean-Marie Lehn was giving a speech on stage |
| Professor Jean-Marie Lehn was visiting the campus, accompanied by the management of Huashang College |
| Professor Jean-Marie Lehn took a picture with the management of Huashang College and
students from Healthcare and Medical Institute
|
On 2 November 2019, Professor Jean-Marie Lehn accepted the invitation by Professor Albert Sun-Chi Chan, the Principal of Huashang College and gave the academic speech of "Walk Into Life Science: Chemistry? Chemistry!" in Huashang College. Before the academic speech, Mr. Liu Yung Chau, Chairman of the Board of Edvantage Group gave the welcome speech and is please to announce to appoint Professor Jean-Marie Lehn as the Honorary Principal of Huashang College under the Group.
After the speech presented by Professor Jean-Marie Lehn, who visited the "Chinese Medicine Specimen Centre" and "Chinese Medicine Verification Laboratory" of the newly established Healthcare and Medical Institute accompanied by the management of Huashang College. Professor Albert Sun-Chi Chan introduced the center, relevant specimens and the educational facilities. Professor Jean-Marie Lehn highly recognized the excellent environment of teaching facilities and was confident in the future development of the Healthcare and Medical Institute. In the future, Professor Jean-Marie Lehn, as the Honorary Principal of Huashang College, will assist the college to be the leading Healthcare and Medical Institute with world-class academic excellence in the Guangdong-Hong Kong-Macau Greater Bay Area. This will definitely provides the student of Huashang College with international prospective and world's leading academic knowledge, as well as will make a great contribution to China's medical and pharmaceutical industry.
The appointment of Professor Jean-Marie Lehn as the Honorary Principal will significantly enhance our competitive advantages in many aspects. First of all, Professor Jean-Marie Lehn is the world-class leading scientist in international academic field that should increase the worldwide recognition of our "Huashang" education brand. Secondly, with the appointment of Professor Jean-Marie Lehn, it will help the newly established Healthcare and Medical Institute to attract leading professors and teachers to join Huashang College's teaching team and attract high quality students to study this profession. Thirdly, Professor Jean-Marie Lehn is an academician of various academic institutes, who always travels around the world to give speeches, will brings greatest momentum for our internationalization development.
About Edvantage Group Holdings Limited Edvantage Group Holdings Limited (HK: 0382) is the largest private higher education group in the Guangdong-Hong Kong-Macau Greater Bay Area (in terms of total student enrolment of business majors for the 2017/2018 school year), and an early mover in education sector in pursuing international expansion. With a sizeable student base, the Company operates with economies of scale. The Edvantage Group currently operates two private higher education institutions located in the Great Bay Area of Guangdong Province, China, namely Huashang College and Huashang Vocational College. Huashang College and Huashang Vocational College focus their programme offerings on business programmes, such as accounting, finance, economics and business English, and strive to help students to achieve employment prospects when they graduate, and to benefit from the availability of employment opportunities in the Greater Bay Area. The Company also operates a private vocational education institution named Global Business College of Australia ("GBCA") in Australia, offering vocational education courses and non-formal short-term courses aiming to provide students with competitive advantages and global prospective. GBCA is a registered training organization authorized by ASQA. The Company believes that GBCA represents a replicable example for its future international expansion, and the Company is exploring international opportunities in Singapore and the London.
About Jean-Marie Lehn Professor Jean-Marie Lehn is the Professor of Chemistry Faculty in University of Strasbourg and a well-known French chemist in the world. He received the Nobel Prize in Chemistry together with Donald Cram and Charles Pedersen in 1987 for his synthesis of cryptands at the age of 48. Then, Professor Jean-Marie Lehn promoted "supramolecular chemistry" around the world and was acclaimed as an early innovator / the father in the field of supramolecular chemistry. Professor Jean-Marie Lehn is the honorable member of many international academic societies, including the Academician of French Academy of Sciences, the Foreign Academician of National Academy of Sciences in the United States and the Foreign Academician of Chinese Academy of Sciences.
Sectors: Daily Finance, Daily News
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025 Nov 22, 2024 11:00 JST
| NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth Nov 21, 2024 22:59 JST
| Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan Nov 21, 2024 15:35 JST
| Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP Nov 21, 2024 09:00 JST
| ALL Study Groups Using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study Nov 20, 2024 23:05 JST
| Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center Nov 20, 2024 15:30 JST
| Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan Nov 20, 2024 11:51 JST
| Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements Nov 20, 2024 10:24 JST
| Kingsoft Announces 2024 Third Quarter Results Nov 19, 2024 18:54 JST
| NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System Nov 19, 2024 15:30 JST
| Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings Nov 19, 2024 09:02 JST
| CleverTap Recognized as a Strong Performer in Cross-Channel Marketing Hubs, Q4 2024 Report Nov 18, 2024 23:30 JST
| World's First Successful Trial of Quantum Tokens Created Using Quantum Technology Nov 18, 2024 17:29 JST
| Fujitsu and SAP Fioneer enter partnership to accelerate digital transformation in the insurance industry and deliver services that contribute to customers' sustainable business Nov 18, 2024 12:31 JST
| Expanding Possibilities with the Liquid Hydrogen-Powered GR Corolla in the Season Final Round Nov 18, 2024 09:25 JST
| COP29: Indonesian Special Envoy Hashim Djojohadikusumo Announces EUR 1,2 Billion Green Funding Nov 16, 2024 18:00 JST
| Mitsubishi Shipbuilding Holds Christening and Launch Ceremony of LNG-Powered Roll-on/Roll-off Ship TRANS HARMONY EMERALD in Shimonoseki Nov 15, 2024 18:58 JST
| Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment) Nov 15, 2024 17:33 JST
| Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease Nov 15, 2024 14:31 JST
| Resorttrust Group and Mitsubishi Corporation Launch Joint Study in Medical Tourism Nov 15, 2024 12:32 JST
|
More Latest Release >>
|